Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
CNOT6L - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
ZNF217 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TMF1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
FAM199X - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
MICU3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
UGCG - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PTER - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
YIPF5 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CREB1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CD164 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SEC24A - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ATAD1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
RAB12 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SMAD4 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SERPINB1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Profile neighbors
RNF20 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SLC38A6 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
VPS37C - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on